Clinical Trial Update: Non-inferiority Study of ZK-A03 in Treatment of Herpes Zoster Before and After the Alteration of the Active Ingredient Manufacturer [Phase 3]

View source ↗

Summary

A Phase 3 non-inferiority trial evaluating ZK-A03 for herpes zoster following an alteration of the active ingredient manufacturer; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• ZK-A03

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Herpes Zoster | Phase 3 | Status: UNKNOWN